IVF Time-lapse Imaging Devices Market Size, Share, Report 2022 to 2030

According to Vision Research Reports, the global IVF time-lapse imaging devices market was valued at USD 282.7 million in 2021 and it is predicted to surpass around USD 1.95 billion by 2030 with a CAGR of 23.93% from 2022 to 2030

Report Highlights

• In 2021, the fertility clinics segment dominated the market for IVF time-lapse imaging devices and held the largest revenue share of 77.7%.
• The hospitals and other settings segment is anticipated to witness the fastest CAGR of 24.52% in the market for IVF time-lapse imaging devices over the forecast period. 
• In 2021, Europe dominated the market for IVF time-lapse imaging devices and accounted for a revenue share of 36.71%.
• In the Asia Pacific, the market for IVF time-lapse imaging devices is projected to witness a promising growth rate over the forecast period. 

Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/39413

Infertility is being driven by lifestyle as well as behavioral changes that reflect a rising proportion of working women, advanced maternal and paternal age, reduced marriage rates, and marriage postponement.

The demand for IVF solutions is on the rise due to the increasing number of people facing issues with naturally conceiving. The rising rate of obesity adds substantially to the incidence of infertility, as obese women are more vulnerable to infertility and uterine disorders. According to the WHO, one out of every six couples experiences issues related to infertility. In India, over 3 million people in India actively sought IVF in 2019. During the COVID-19 pandemic, the IVF market was affected as the number of individuals opting for IVF and IUI procedures reduced significantly. The percentage of people undertaking IVF cycles globally fell by 90%.

COVID-19 imposed significant changes including paving the way for the sector's digital adoption. To survive and thrive in challenging times, the global IVF market was pushed to prioritize operational efficiency and telehealth implementation. Moreover, since 2019 the fertility market has been one of the top six most-invested treatment areas. As per Crunchbase website data, the global investments in fertility startups have increased by 89 percent from USD 93 million in 2020 to USD 176 million in 2021.

Artificial intelligence can be used to automate processes that are prone to human-derived subjectivity as well as variability. As clinics encounter rising patient demand, which frequently necessitates more and more advanced techniques, there is a clear need to automate as many procedures as possible to ensure the standard treatment quality while optimizing clinic resources. For instance, in April 2021, Life Whisperer announced a notable advancement in using AI to help embryologists rank and choose genetically better and healthier embryos in IVF without invasive procedures. Life Whisperer Genetics, a new AI product, necessitates only camera images of embryos to evaluate their genetic integrity. The AI analyses the physical morphology of the embryo based on the images to ascertain whether the embryo is genetically standard (euploid) and has a complete set of chromosomes.

Scope of The Report

End-use Insights

In 2021, the fertility clinics segment dominated the market for IVF time-lapse imaging devices and held the largest revenue share of 77.7% owing to the growing preference for clinics to undergo IVF treatments. As per the Department of Health and Human Services, approximately 12 to 13 couples out of every 100 face difficulty in conceiving. Since the continuous rise of infertility, more people are turning to IVF services, which is fueling segment growth.

The hospitals and other settings segment is anticipated to witness the fastest CAGR of 24.52% in the market for IVF time-lapse imaging devices over the forecast period. The rising incidence of infertility, the rapid implementation of assisted reproductive technologies in hospitals, the constantly progressing healthcare infrastructure, and the growing availability of well-resourced infrastructure are the key factors driving the segment growth.

Regional Insights

In 2021, Europe dominated the market for IVF time-lapse imaging devices and accounted for a revenue share of 36.71% owing to rising infertility cases and growing fertility tourism in the region. An increasing number of people are traveling to European countries such as Spain, the Czech Republic, and others to receive IVF treatments at a cheaper cost. Moreover, regulations such as the U.K. Human Fertilisation and Embryology Authority (HFEA), which strictly regulates IVF treatments in the U.K. are supporting the market trends. In Germany, due to the falling birth rate of around 2.21 children per woman, IVF treatment subsidies are an important factor in the market growth. In addition, the National Health Plan covers roughly half of the total cost of treatment. It supports three IVF cycles, which is expected to drive the market for IVF time-lapse imaging devices.

In the Asia Pacific, the market for IVF time-lapse imaging devices is projected to witness a promising growth rate over the forecast period. This growth can be attributed to increased awareness of IVF treatments, lower prices, and growth in the rate of infertility. Moreover, as per the Beilstein Journal of Organic Chemistry (BJOC), the Chinese childbearing population discovered that approximately 25% of Chinese women aged 20-49 who wanted to have a child were infertile.

Since the lifting of China's Family Planning policy couples now has the liberty to expand their families or have more children. As per China's National Health and Family Planning Commission, after the policy was relaxed, approximately 90 million Chinese women have become eligible to have a second child, moreover Chinese hospitals noted more second children born than first children in 2017.

Key Players

• Vitrolife Sweden AB,
• Esco Medical Technologies UAB
• Genea Biomedx PYT LTD.
• ASTEC CO., LTD.

Market Segmentation

• By End-use Outlook
  • Hospitals & Other Settings
  • Fertility Clinics
• By Regional Outlook
  • North America

• • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Click Here to View Full Report Table of Contents

Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39413

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333